erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Rhinitis D012220 10 associated lipids
Skin Ulcer D012883 6 associated lipids
Heart Diseases D006331 8 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Multiple Myeloma D009101 13 associated lipids
Quadriplegia D011782 4 associated lipids
Pain, Postoperative D010149 13 associated lipids
Porphyrias D011164 2 associated lipids
Femoral Fractures D005264 7 associated lipids
Hematuria D006417 13 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Weight Gain D015430 101 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Endocarditis, Bacterial D004697 5 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Salpingitis D012488 2 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Fractures, Open D005597 3 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Crohn Disease D003424 12 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Cholestasis D002779 23 associated lipids
Sinusitis D012852 9 associated lipids
Glomerulonephritis D005921 35 associated lipids
Sepsis D018805 11 associated lipids
Nervous System Diseases D009422 37 associated lipids
Enterocolitis, Pseudomembranous D004761 8 associated lipids
Ataxia D001259 20 associated lipids
Psoriasis D011565 47 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Cross Infection D003428 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Wound Infection D014946 12 associated lipids
Bacteriuria D001437 7 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Matsunaga H et al. Manometric evidence of improved early gastric stasis by erythromycin after pylorus-preserving pancreatoduodenectomy. 2000 World J Surg pmid:11071469
Raahave D et al. Cefotaxime i.v. versus oral neomycin-erythromycin for prophylaxis of infections after colorectal operations. 1988 World J Surg pmid:3041682
Krone LV The importance of multiple antibiotic coverage for hospitalized patients when the community acquired pneumonia is Legionnaire's disease. 1998 WMJ pmid:9617308
Rytel MW and Coonrod JD Therapy of viral, mycoplasmal and rickettsial infections. 1971 Wis. Med. J. pmid:4101370
Chusid MJ et al. Neutropenia in dysgammaglobulinemia I: remission with immunoglobulin therapy. 1981 Wis. Med. J. pmid:7281709
Larratt K et al. Sporadic cases of Legionnaires' disease in Wisconsin: epidemiologic and clinical characteristics. 1980 Wis. Med. J. pmid:7210696
Horn S et al. Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate. 1999 Wien. Klin. Wochenschr. pmid:10081126
KARPINSKI W [The use of erythromycin in pediatry]. 1955 Wien. Klin. Wochenschr. pmid:13247878
Kalenda J [New, in Austria registered specialty drugs. Aknemycin 1% compositum. Hydrophilic ointment with color paste]. 1992 Wien. Klin. Wochenschr. pmid:1355937
PROTIVINSKY R and ZELLINGER O [Therapy of mixed infection tuberculous empyema; preliminary report]. 1958 Wien. Klin. Wochenschr. pmid:13570054
Zinnecker HJ et al. [Posttraumatic infection with a lactose splitting variant of Pasteurella multocida]. 1970 Wien. Klin. Wochenschr. pmid:4998002
Zagar Z [Antimicrobial therapy and public health]. 1967 Wien. Klin. Wochenschr. pmid:5185251
Fanta D and Niebauer G [Progress in medicine in individual presentations, XI. Modern forms of therapy in acne]. 1977 Wien. Klin. Wochenschr. pmid:73259
Luger A [Syphilis diagnosis in the age of antibiotics]. 1971 Wien. Klin. Wochenschr. pmid:5559788
Breitfellner G et al. [Staphylococci in the Vienna area. Epidemiology, antibiotic sensitivity and therapeutic aspects]. 1968 Wien. Klin. Wochenschr. pmid:5188335
Assadian O et al. Prophylaxis of ophthalmia neonatorum--a nationwide survey of the current practice in Austria. 2002 Wien. Klin. Wochenschr. pmid:12238308
Breitfellner G and Neuhold R [Yearly variations of the lysotype and resistance picture of staphylococci]. 1968 Wien. Klin. Wochenschr. pmid:4232544
Leskova R and Neumeister E [Determination of erythromycin excretion time in the milk following intramammary administration]. 1969 Wien Tierarztl Monatsschr pmid:5818871
Ploier R et al. [Campylobacter jejuni infections in children]. 1985 Wien Med Wochenschr pmid:3895753
Zechner G [The value of targeted antibiotic therapy based on the example of streptococcal infections with special reference to late side effects]. 1983 Wien Med Wochenschr pmid:6559004
MULLER WK [Erythromycin treatment of spinal pachy- and leptomeningitis with a contribution to the clinical picture of spinal epidural abscess]. 1958 Wien Med Wochenschr pmid:13581715
Hatzenberger H [Atypical migrating pneumonia]. 1972 Wien Med Wochenschr pmid:5079728
Lagrange PH [Round table discussion "Josamycin and macrophages: a preferred relationship]. 1988 Wien Med Wochenschr pmid:3407204
Spitzy KH [Ecological viewpoints in antibacterial chemotherapy]. 1970 Wien Med Wochenschr pmid:4918431
Rauter G [Comparative studies on antibiotic sensitivity of staphylococci and enterococci in reference to the effect of oleandomycin]. 1972 Wien Med Wochenschr pmid:4484875
Arct WA [Carpal lesion due to brucellosis]. 1970 Wiad. Lek. pmid:5482241
Rudzki S et al. [Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding]. 2006 Wiad. Lek. pmid:17209345
Gebka W et al. [Case of consumption coagulopathy during staphylococcal septicemia]. 1971 Wiad. Lek. pmid:5139150
Czambor-Ksiazek E et al. [Disorders of gastric emptying in diabetes. II. Treatment]. 1997 Wiad. Lek. pmid:9297356
DIPHTHERIA carriers rapidly cleared. 1953 Whats New pmid:24542774
PYODERMA responds to erythromycin ointment. 1953 Whats New pmid:24542848
ERYTHROMYCIN; a current appraisal. 1954 Whats New pmid:24543301
ERYTHROCIN in trachoma. 1954 Whats New pmid:24543306
ERYTHROMYCIN prophylaxis against ophthalmia neonatorum. 1956 Whats New pmid:24544143
Legionnaires' disease. 1978 West. J. Med. pmid:735046
Zechnich AD et al. Possible interactions with terfenadine or astemizole. 1994 West. J. Med. pmid:8023479
Siegel D Management of community-acquired pneumonia in outpatients. 1985 West. J. Med. pmid:3976218
Updike WS et al. Successful medical treatment of listerial brain abscess. 1990 West. J. Med. pmid:2333704
Marinella MA More on lovastatin. 1995 West. J. Med. pmid:7725700
Barrett-Connor E Current status of the treatment of syphilis. 1975 West. J. Med. pmid:1089007
Frick PA et al. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State. 1998 West. J. Med. pmid:9866434
Forquer BD and Linthicum FH Middle ear effusion in children: a report of treatment in 500 cases. 1982 West. J. Med. pmid:6184891
Spach DH et al. Rhabdomyolysis associated with lovastatin and erythromycin use. 1991 West. J. Med. pmid:2006579
Covelli HD et al. Psittacosis: clinical presentation and therapeutic observations. 1980 West. J. Med. pmid:7376661
Polley RF Use of erythromycin-sulfas in office practice. 1966 West Med Med J West pmid:6013699
Nwako F Proceedings: Effect of pre-operative antibiotic regimen on development of infection after intestinal surgery. 1975 West Afr J Pharmacol Drug Res pmid:775790
Wang C et al. [Study of the genetic stability of expression plasmid vector pMG36e in host bacteria]. 2005 Wei Sheng Yan Jiu pmid:15952668
Wang QX et al. [To inquire into the classifiable position of Streptomyces erythreus 2577]. 1986 Wei Sheng Wu Xue Bao pmid:3751016
Yuan SF et al. Levels of six antibiotics used in China estimated by means of wastewater-based epidemiology. 2016 Water Sci. Technol. pmid:26901719
Aydın S et al. The joint acute effect of tetracycline, erythromycin and sulfamethoxazole on acetoclastic methanogens. 2015 Water Sci. Technol. pmid:25909721